Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Platinum Management (NY) LLC (CIK 1368616) reported $16.4M across 5 reported positions in its SEC 13F filing for 2016-03-31. Largest positions: NAVB ($14.7M, 89.51%), ECTE ($1.1M, 6.61%), PED ($631,000, 3.84%), IDEX ($6,000, 0.04%), NSPR ($1,000, 0.01%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | NAVB | NAVIDEA BIOPHARMACEUTICALS I | $14.7M | 89.51% | 15.6M | Added |
| 2 | ECTE | ECHO THERAPEUTICS INC | $1.1M | 6.61% | 829,183 | Hold |
| 3 | PED | PEDEVCO CORP | $631,000 | 3.84% | 3.4M | Added |
| 4 | IDEX | YOU ON DEMAND | $6,000 | 0.04% | 3,015 | Hold |
| 5 | NSPR | INSPIREMD INC | $1,000 | 0.01% | 2,445 | Hold |
Source: SEC Form 13F filings · as of 2016-03-31